The Single Nucleotide Polymorphism, CRTh2-6373G>A, is Associated with Allergic Asthma and Increased Expression of CRTh2

被引:0
|
作者
Cameron, L. [1 ]
Alberto, E. Campos [1 ]
MacLean, E. [1 ]
Davidson, C. [1 ]
Brenner, D. [2 ]
El-Sohemy, A. [2 ]
Vliagoftis, H. [1 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
D O I
10.1016/j.jaci.2011.12.694
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB53 / AB53
页数:1
相关论文
共 50 条
  • [21] The therapeutic potential of CRTH2/DP2 beyond allergy and asthma
    Jandl, Katharina
    Heinemann, Akos
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2017, 133 : 42 - 48
  • [22] Peripheral Blood Crth2 Positive Cells In Patients With Severe Asthma
    Xue, L.
    Hilvering, B.
    Shrimanker, R.
    Stoeger, L.
    Go, S.
    Borg, C.
    Connolly, C.
    Thulborm, S.
    Pahlke, S.
    Bafadhel, M.
    Pavord, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Selective prostaglandin DP2 (CRTh2) inhibitor Treatment of asthma
    Singh, J.
    Saroj, P.
    Kumar, B.
    Kuhad, A.
    DRUGS OF THE FUTURE, 2018, 43 (08) : 565 - 572
  • [24] Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
    Erpenbeck, Veit J.
    Popov, Todor A.
    Miller, David
    Weinstein, Steven F.
    Spector, Sheldon
    Magnusson, Baldur
    Osuntokun, Wande
    Goldsmith, Paul
    Weiss, Markus
    Beier, Jutta
    DATA IN BRIEF, 2016, 9 : 199 - 205
  • [25] Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma
    Lee, Hea Yon
    Lee, Hwa Young
    Hur, Jung
    Kang, Hye Seon
    Choi, Joon Young
    Rhee, Chin Kook
    Kang, Ji Young
    Kim, Young Kyoon
    Lee, Sook Young
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03): : 619 - 629
  • [26] Genetic Variability Of Crth2 Polymorphism Is Associated With The Required Dose Of Antihistamines In Patients With Chronic Urticaria
    Palikhe, N. Shrestha
    Kim, S. H.
    Ye, Y. M.
    Hur, G. Y.
    Park, H. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S150 - S150
  • [27] Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric Mucosa
    Rajapaksa, Kathila S.
    Huang, Tao
    Sharma, Neeraj
    Liu, Shannon
    Solon, Margaret
    Reyes, Arthur
    Paul, Sarah
    Yee, Angie
    Tao, Janet
    Chalasani, Sreedevi
    Bien-Ly, Nga
    Barck, Kai
    Carano, Richard A. D.
    Wang, Jianyong
    Rangell, Linda
    Bremer, Meire
    Danilenko, Dimitry M.
    Katavolos, Paula
    Hotzel, Isidro
    Reif, Karin
    Austin, Cary D.
    TOXICOLOGICAL SCIENCES, 2016, 152 (01) : 72 - 84
  • [28] Preclinical safety profile of a depleting antibody against CRTh2 for asthma: Well tolerated despite unexpected CRTh2 expression on vascular pericytes in the central nervous system and gastric mucosa
    Austin, Cary D.
    Huang, Tao
    Sharma, Neeraj
    Liu, Shannon
    Solon, Margaret
    Reyes, Arthur
    Paul, Sarah
    Yee, Angie
    Tao, Janet
    Chalasani, Sreedevi
    Bien-Ly, Nga
    Barck, Kai
    Carrano, Richard A. D.
    Wang, Jianyong
    Rangell, Linda
    Bremer, Miere
    Danllenko, Dimitry M.
    Katavolos, Paula
    Hotzel, Isidro
    Reif, Karen
    Rajapaksa, Kathila S.
    FASEB JOURNAL, 2016, 30
  • [29] SINGLE- AND MULTIPLE-DOSE TOLERABILITY AND PHARMACOKINETICS OF THE CRTH2 ANTAGONIST ACT-CRTH2 IN HEALTHY SUBJECTS
    Sidharta, Patricia N.
    Diamant, Zuzana
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1096 - 1096
  • [30] Small-molecule CRTH2 antagonists for the treatment of allergic inflammation: an overview
    Ly, TW
    Bacon, KB
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (07) : 769 - 773